CAP checklist item: 11.3072

Sandy.Jaquette@parkview.com
Thursday, 23 October 1997 2:20pm CT

If CD19 is used in tangent with Kappa/Lambda antibodies, the Kappa+ or Lambda+
B cells can be identified even with cytophilic Ig present on the cells. We
routinely run 3-color 19/Kappa/Lambda, but do not routinely add FCS to all
our leukemias/lymphomas. Does question 11.3072 on the CAP checklist mean
that all leukemias/lymphomas should be pre-treated?